| 1. |
REVIEW OF SECOND PRIMARY TUMORS IN PATIENTS WITH HEAD AND NECK CANCER IN KBC OSIJEK FROM 2017 TO 2021 |
KOTROMANOVIĆ DARKO |
|
| 2. |
ASSESSMENT OF CUTANEOUS TOXCITIY IN CANCER PATIENTS TREATED WITH CDK 4/6 INHIBITORS AND ENDOCRINE THERAPY ACCORDING TO PATIENT-RELATED OUTCOMES AT THE UNIVERSITY HOSPITAL FOR TUMORS |
JAKŠIĆ PETRA |
|
| 3. |
ASSOCIATION BETWEEN PRETREATMENT NEUTROPHIL-TO-LYMPHOCYTE RATIO AND OUTCOME OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB – A SINGLE INSTITUTION ANALYSIS |
FRANCESCHI DORA |
|
| 4. |
ASSOCIATIONS OF TILS COMPONENTS CD8, CD4, PD-L1, CTLA4 AND FOXP3 IN TRIPLE NEGATIVE BREAST CARCINOMA WITH THE CLINICOPATHOLOGICAL PROGNOSTIC FACTORS |
NOVAK KOSJENKA |
|
| 5. |
BREATHING EXERCISE IMPACT ON QUALITY OF LIFE WITH LUNG CANCER PATIENTS |
EŽBEGOVIĆ BRUNO |
|
| 6. |
CASE REPORT: MAYBE COVID-19 SAVES LIVES AFTER ALL? ACCIDENTALLY FOUND LUNG TUMOR IN COVID-19 INFECTION. |
BOŠNJAK ANA |
|
| 7. |
CERVICAL CANCER IN PREGNANCY - A CASE REPORT |
PARADŽIK PAŠALIĆ VANDA |
|
| 8. |
CLINICAL CHARACTERISTICS OF PATIENTS WITH HEREDITARY BREAST AND OVARIAN CANCER – SINGLE CENTRE EXPERIENCES FROM UNIVERSITY HOSPITAL OF SPLIT |
PETRIĆ MIŠE BRANKA |
|
| 9. |
CLINICAL OUTCOMES OF PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER TREATED WITH PEMBROLIZUMAB MONOTHERAPY OR IN COMBINATION WITH CHEMOTHERAPY – UPDATED ANALYSIS OF A SINGLE CENTER EXPERIENCE |
BRČIĆ HRVOJE |
|
| 10. |
COLLABORATION OF DALMATIAN HOSPITALS: IMPACT OF COVID-19 ON THE REPORTED INCIDENCE OF BREAST CANCER IN THE FIRST WAVE OF THE PANDEMIC IN DALMATIA |
NALBANI MARIO |
|
| 11. |
COMBINATION OF THE GEMCITABINE AND PACLITAXEL IN THE SECOND LINE TREATMENT SETTING AFTER PROGRESSION TO FOLFIRINOX - A SINGLE INSTITUTION ANALYSIS AT THE DEPARTMENT OF ONCOLOGY AND RADIOTHERAPY, UNIVERSITY HOSPITAL OF SPLIT |
ČERINA DORA |
|
| 12. |
COMPARISON OF ER AND PR RECEPTOR AND HER2 ANALYSIS BETWEEN CELL BLOCKS AND PATHOLOGY SAMPLES |
RAMLJAK VESNA |
|
| 13. |
COMPARISON OF PERCUTANEOUS CT-GUIDED MICROWAVE ABLATION AND PARTIAL NEPHRECTOMY IN THE TREATMENT OF T1A RENAL CARCINOMA |
RADIĆ PETRA |
|
| 14. |
COMPARISON OF RADIOTHERAPY TECHNIQUES – EXPERIENCES OF A UNIVERSITY HOSPITAL |
BELIĆ DINO |
|
| 15. |
COMPARISON OF THREE CALCULATION ALGORITHMS FOR POST-OPERATIVE RADIOTHERAPY OF BREAST CANCER |
OBAJDIN NEVENA |
|
| 16. |
COMPREHENSIVE GENOMIC PROFILING (CGP) IN THE UPFRONT DIAGNOSTIC WORKUP OF LOCALLY ADVANCED OR METASTATIC OVARIAN CANCER- A SINGLE INSTITUTION ANALYSIS |
ČERINA DORA |
|
| 17. |
COVID 19 IMPACT ON REPORTED INCIDENCE OF COLORECTAL CANCER DURING THE FIRST WAVE OF PANDEMIC IN DALMATIA |
TELESMANIĆ DOBRIĆ VESNA |
|
| 18. |
COVID-19 PANDEMIC IMPACT ON RADIOTHERAPY IN PATIENTS WITH HEAD AND NECK CANCER |
TOMIĆ KREŠIMIR |
|
| 19. |
DEVELOPMENT AND IMPLEMENTATION OF 2D RADIOCHROMIC FILM DOSIMETRY METHODOLOGY FOR VERIFICATION OF ADVANCED RADIATION THERAPY TECHNIQUE DELIVERY AS A PART OF IAEA CRO 6019 PROJECT |
RAJLIĆ DAVID |
|
| 20. |
DURVALUMAB IN THE TREATMENT OF STAGE III NSCLC – SINGLE CENTER EXPERIENCE |
BOŠKOVIĆ LIDIJA |
|
| 21. |
EFFICACY AND SAFETY OF OLAPARIB IN THE TREATMENT OF BRCA MUTATED OVARIAN CANCER – SINGLE CENTRE EXPERIENCE FROM UNIVERSITY HOSPITAL OF SPLIT |
PETRIĆ MIŠE BRANKA |
|
| 22. |
EFFICACY OF RAMUCIRUMAB IN COMBINATION WITH PACLITAXEL IN THE SECOND LINE TREATMENT OF METASTATIC GASTRIC CANCER – RETROSPECTIVE ANALYSIS FROM THREE CROATIAN ONCOLOGY CENTERS |
OMRČEN TOMISLAV |
|
| 23. |
FOLFIRINOX VS. GEMCITABINE + NAB-PACLITAXEL IN THE FIRST LINE TREATMENT SETTING OF METASTATIC PANCREATIC CANCER- A SINGLE INSTITUTION ANALYSIS OF THE OUTCOMES |
BULJUBAŠIĆ FRANIĆ MATEA |
|
| 24. |
HOW OFTEN ONCOLOGISTS RECORD THE PATIENTS’ COVID-19 INFECTION IN THEIR FINDINGS |
BERIĆ JOZIĆ GORDANA |
|
| 25. |
HOW TO SEQUENCE CHEMOTHERAPY AFTER PROGRESSION TO OLAPARIB MAINTENANCE THERAPY IN PATIENTS WITH BRCA MUTATED OVARIAN RECURRENCE? – SINGLE CENTRE EXPERIENCE FROM UNIVERSITY HOSPITAL OF SPLIT |
PETRIĆ MIŠE BRANKA |
|
| 26. |
IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF METASTATIC UROTHELIAL CANCER: A SINGLE-CENTER RETROSPECTIVE STUDY |
MURGIĆ JURE |
|
| 27. |
IMPACT OF THE COVID-19 PANDEMIC ON BREAST CANCER PRESENTATION AT UHC SESTRE MILOSRDNICE |
URCH KRISTINA |
|
| 28. |
INPATIENT ONCOLOGY CARE – IMPACT OF COVID-19 PANDEMIC, SINGLE-CENTER EXPERIENCE |
BERIĆ JOZIĆ GORDANA |
|
| 29. |
IS FRONTOLATERAL LARYNGECTOMY STILL USEFUL PROCEDURE IN THE TREATMENT OF LARYNGEAL MALIGNANCY IN THE MODERN ERA? |
TUDOR FILIP |
|
| 30. |
LONG-LASTING COMPLETE RESPONSE ON THIRD-LINE IMMUNOTHERAPY IN PATIENT WITH MALIGNANT PLEURAL MESOTHELIOMA – CASE REPORT |
ČULJAK ŽELJKA |
|
| 31. |
MASTECTOMY SHOULD NOT BE OFFERED TO THE EARLY-STAGE BREAST CANCER PATIENTS |
CAR PETERKO ANA |
|
| 32. |
MELANOMA PATIENTS WITH BRAIN METASTASIS – A SINGLE-CENTER EXPERIENCE |
URCH KRISTINA |
|
| 33. |
MULTIPARAMETIC MAGNETIC RESONANCE IMAGING FOR BLADDER CARCINOMA |
GULJAŠ SILVA |
|
| 34. |
NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER, ATM MUTATION CARRIERS |
PLEŠKO EVA |
|
| 35. |
OUTCOME OF PATIENTS WITH ADVANCED LARYNGEAL CARCINOMA - A MULTICENTRIC RETROSPECTIVE STUDY |
MARIJIĆ BLAŽEN |
|
| 36. |
PALLIATIVE RADIOTHERAPY (PR) FOR BONE METASTASES – PATTERNS OF CARE AND OUTCOMES ANALYSIS FROM A LARGE TERTIARY CENTER |
VRLJIČAK ANTONELA |
|
| 37. |
PATIENTS WITH LEPTOMENINGEAL METASTASES, THEIR TREATMENT AND OUTCOME |
PERIĆ LUKA |
|
| 38. |
PATOLOGICAL CHARACTERISTICS AND SPECTRUM OF BRCA MUTATIONS IN PATIENTS WITH HEREDITARY BREAST AND OVARIAN CANCER – SINGLE CENTRE EXPERIENCES FROM UNIVERSITY HOSPITAL OF SPLIT |
PETRIĆ MIŠE BRANKA |
|
| 39. |
POSITIONING OF INTRAOPERATIVE RADIOTHERAPY IN BREAST CANCER TREATMENT |
ANTUNAC KATARINA |
|
| 40. |
PREHABILITATION IN GASTROINTESTINAL CANCER PATIENTS |
KIRAC IVA |
|
| 41. |
PROSTATE CANCER IN THE FIRST WAVE OF PANDEMIC: HAS COVID-19 CHANGED THE PERSPECTIVE OF PROSTATE CANCER |
JAJAC BRUČIĆ LANA |
|
| 42. |
RE-PLANNING IN GAMMA KNIFE RADIOSURGICAL CENTRE |
BATURINA BLANKA |
|
| 43. |
SETTING UP THE FIRST QUALITY-ASSURED SPECIALIZED BREAST CENTRE IN CROATIA |
CAR PETERKO ANA |
|
| 44. |
SINDROM KOMPRESIJE KRALJEŽNIČNE MOŽDINE-RADIOTERAPIJA |
RENDIĆ-MIOČEVIĆ ZRINKA |
|
| 45. |
SINGLE INSTITUTION EXPERIENCE WITH NIVOLUMAB AS SECOND LINE THERAPY IN ADVANCED RENAL CELL CARCINOMA: EXPLORATORY ANALYSIS OF PROGNOSTIC FACTORS |
MURGIĆ JURE |
|
| 46. |
SPECTRUM OF BRCA1 AND BRCA2 MUTATIONS IN PATIENTS WITH HIGH GRADE SEROUS OVARIAN CANCER IN DALMATIA – SINGLE CENTRE EXPERIENCE FROM UNIVERSITY HOSPITAL OF SPLIT |
PETRIĆ MIŠE BRANKA |
|
| 47. |
SPECTRUM OF RADIOLOGICAL IMAGING FINDINGS OF IMMUNE-CHECKPOINT BLOCKADE FOR LUNG CANCER AT UNIVERSITY HOSPITAL CENTRE OSIJEK |
KRIVDIĆ DUPAN ZDRAVKA |
|
| 48. |
SPECTRUM OF RADIOLOGICAL IMAGING FINDINGS OF SPECIFIC TARGET THERAPY FOR LUNG CANCER AT UNIVERSITY HOSPITAL CENTRE OSIJEK |
KRIVDIĆ DUPAN ZDRAVKA |
|
| 49. |
SUBTYPING OF TRIPLE-NEGATIVE BREAST CANCER |
RAMIĆ SNJEŽANA |
|
| 50. |
THE POTENTIAL OF COMBINATION THERAPY WITH FULVESTRANT AND LETROZOLE IN NEOADJUVANT HORMONAL THERAPY OF BREAST CANCER |
MAJIĆ ANA |
|
| 51. |
THE TREATMENT RESULTS OF MRCC PATIENTS 6 YEARS AFTER FIRST APPLICATION OF NIVOLUMAB AS SECOND LINE THERAPY |
GAMULIN MARIJA |
|
| 52. |
THE UNMET NEEDS OF CANCER PATIENTS - A STEP FORWARD |
ERCEG TUŠEK MAJA |
|
| 53. |
THE UP-DATED INSIGHT INTO IMMUNOTHERAPY WITH CHECKPOINT INHIBITORS IN PATIENTS WITH METASTATIC COLORECTAL CANCER - OUR DAILY PRACTICE |
VICULIN JELENA |
|
| 54. |
TRANSITION TROUGHOUT THE TREATMENT LINES AND THE OUTCOMES OF METASTATIC PANCREATIC CANCER AT THE DEPARTMENT OF ONCOLOGY AND RADIOTHERAPY, UNIVERSITY HOSPITAL OF SPLIT DURING 2018-2021- A RETROSPECTIVE ANALYSIS. |
ŠUTO JELENA |
|
| 55. |
TREATMENT OF PATIENTS WITH ESOPHAGEAL CARCINOMA - EXPERIENCE OF THE DEPARTMENT OF ONCOLOGY, UNIVERSITY HOSPITAL OF SPLIT |
BOBAN MARIJO |
|
| 56. |
TREATMENT PATTERNS AND SURVIVAL OUTCOMES OF PATIENTS WITH METASTATIC GASTRIC CANCER AT THE DEPARTMENT OF ONCOLOGY AND RADIOTHERAPY, UNIVERSITY HOSPITAL OF SPLIT FROM 2018 TO 2020 - A RETROSPECTIVE ANALYSIS. |
KATIĆ ANDRIJA |
|
